EUVIMEDEUVIMED entdecken
Open Access

3D Kinematics Quantifies Gait Response to Levodopa earlier and to a more Comprehensive Extent than the MDS‐Unified Parkinson's Disease Rating Scale in Patients with Motor Complications

Raquel Barbosa iD, Marcelo Mendonça iD, Paulo Bastos iD, Patrícia Pita Lobo, Anabela Valadas, Leonor Correia Guedes, Joaquim J Ferreira, Mário Miguel Rosa, Ricardo Matias, Miguel Coelho

Movement Disorders Clinical Practice · 2024

DOI: 10.1002/mdc3.14016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, 2024. Verfasst von Raquel Barbosa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Deparment, Centre Hospitalier Universitaire Toulouse, Toulouse, France. Hauptthemen laut MEDLINE: Levodopa, Parkinson Disease, Antiparkinson Agents, Gait. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Santa Casa da Misericórdia de Lisboa, Fundação para a Ciência e a Tecnologia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Quantitative 3D movement analysis using inertial measurement units (IMUs) allows for a more detailed characterization of motor patterns than clinical assessment alone. It is essential to discriminate between gait features that are responsive or unresponsive to current therapies to better understand the underlying pathophysiological basis and identify potential therapeutic strategies.

Objectives

This study aims to characterize the responsiveness and temporal evolution of different gait subcomponents in Parkinson's disease (PD) patients in their OFF and various ON states following levodopa administration, utilizing both wearable sensors and the gold‐standard MDS‐UPDRS motor part III.

Methods

Seventeen PD patients were assessed while wearing a full‐body set of 15 IMUs in their OFF state and at 20‐minute intervals following the administration of a supra‐threshold levodopa dose. Gait was reconstructed using a biomechanical model of the human body to quantify how each feature was modulated. Comparisons with non‐PD control subjects were conducted in parallel.

Results

Significant motor changes were observed in both the upper and lower limbs according to the MDS‐UPDRS III, 40 minutes after levodopa intake. IMU‐assisted 3D kinematics detected significant motor alterations as early as 20 minutes after levodopa administration, particularly in upper limbs metrics. Although all “pace‐domain” gait features showed significant improvement in the Best‐ON state, most rhythmicity, asymmetry, and variability features did not.

Conclusion

IMUs are capable of detecting motor alterations earlier and in a more comprehensive manner than the MDS‐UPDRS III. The upper limbs respond more rapidly to levodopa, possibly reflecting distinct thresholds to levodopa across striatal regions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LevodopaParkinson DiseaseAntiparkinson AgentsGaitHumansMaleBiomechanical PhenomenaFemaleAgedMiddle AgedGait Disorders, NeurologicSeverity of Illness Index

Stichwörter der Autor:innen

Parkinson's diseasegaitkinematic analysislevodopa challenge testwearable devices

Substanzen

LevodopaAntiparkinson Agents

Autor:innen und Institutionen

  • Neurology Deparment, Centre Hospitalier Universitaire Toulouse, Toulouse, France.
  • Nova Medical School, Faculdade de Ciências Medicas, Universidade Nova de Lisboa, Lisbon, Portugal.
  • Champalimaud Research and Clinical Centre, Champalimaud Centre for the Unknown, Lisbon, Portugal.
  • Department of Neurosciences and Mental Health, Neurology Hospital Santa Maria, CHLUN, Lisbon, Portugal.
  • Instituto de Medicina Molecular João Lobo Antunes, Faculty of Medicine, University of Lisbon, Lisbon, Portugal.
  • Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.

ORCID-Profile: Raquel Barbosa, Marcelo Mendonça, Paulo Bastos

Förderung

  • Santa Casa da Misericórdia de Lisboa
  • Fundação para a Ciência e a Tecnologia

Zitieren

APA

Barbosa, R., Mendonça, M., Bastos, P., Pita Lobo, P., Valadas, A., Correia Guedes, L., Ferreira, J. J., Rosa, M. M., Matias, R., & Coelho, M. (2024). 3D Kinematics Quantifies Gait Response to Levodopa earlier and to a more Comprehensive Extent than the MDS‐Unified Parkinson's Disease Rating Scale in Patients with Motor Complications. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.14016

Vancouver

Barbosa R, Mendonça M, Bastos P, Pita Lobo P, Valadas A, Correia Guedes L, et al. 3D Kinematics Quantifies Gait Response to Levodopa earlier and to a more Comprehensive Extent than the MDS‐Unified Parkinson's Disease Rating Scale in Patients with Motor Complications. Movement Disorders Clinical Practice. 2024. doi:10.1002/mdc3.14016

BibTeX
@article{Barbosa2024,
  author = {Barbosa, Raquel and Mendonça, Marcelo and Bastos, Paulo and Pita Lobo, Patrícia and Valadas, Anabela and Correia Guedes, Leonor and Ferreira, Joaquim J and Rosa, Mário Miguel and Matias, Ricardo and Coelho, Miguel},
  title = {3D Kinematics Quantifies Gait Response to Levodopa earlier and to a more Comprehensive Extent than the MDS‐Unified Parkinson's Disease Rating Scale in Patients with Motor Complications},
  journal = {Movement Disorders Clinical Practice},
  year = {2024},
  doi = {10.1002/mdc3.14016}
}
Kostenlos starten →